Halozyme is Set to Acquire Elektrofi in a Deal Worth up to $900M, Expanding its Lineup of Drug Delivery Products

Halozyme is buying Elektrofi ($900M) for Hypercon tech. This innovation concentrates powerful biologic drugs for small, easy shots. This means patients can use auto-injectors at home, boosting convenience and treatment access.